Biotech

All Articles

Arrowhead fires off phase 3 data in unusual metabolic health condition in front of market encounter Ionis

.Arrowhead Pharmaceuticals has actually shown its hand ahead of a prospective showdown with Ionis, p...

Pfizer, Valneva reveal lyme illness shot successful for 2nd booster

.Pfizer as well as Valneva may have concerning pair of more years to wait prior to they make the 1st...

Fierce Biotech Managing Editor Ayla Ellison Chats Patronize Michelle Benz on the Future of Biotech.

.Allow's study a conversation along with Ayla Ellison, Intense Biotech Editor-in-Chief as well as Mi...

New records show how Bayer's asundexian fell short to avoid strokes

.Bayer suspended the phase 3 test for its own variable XIa prevention asundexian behind time in 2015...

Sanofi's tolebrutinib neglects 2 of 3 late-stage MS tests

.Sanofi is still bented on taking its own multiple sclerosis (MS) med tolebrutinib to the FDA, execs...

Galapagos' stock up as fund shows intent to mold its own evolution

.Galapagos is actually coming under added tension from clients. Having built a 9.9% risk in Galapago...

Cell- concentrated Sana gathers very first CSO-- Chutes &amp Ladders

.Accept to this week's Chutes &amp Ladders, our roundup of notable management hirings, firings and r...

Allist settles Jacobio $21M, landing duty in Mandarin KRAS race

.Shanghai Allist Pharmaceuticals has purchased itself a starring character in China's KRAS market, p...

ReNeuron leaving intention swap after skipping fundraising objective

.ReNeuron has actually joined the lengthy listing of biotechs to leave Greater london's intention st...

MBX files for IPO to take challenger to Ascendis in to phase 3

.MBX Biosciences has added to the recent spurt of IPO filings. The biotech, which filed its document...